Translational Research for Breast Cancer - Workshop for new research ideas at the Biedenkopf Symposium XIII of the Banss Foundation Joint Symposium of the University Gynecological Hospital Frankfurt, the German Breast Group and the Banss Foundation

被引:0
作者
von Minckwitz, G. [1 ,2 ]
Eidtmann, H. [3 ]
Groner, B. [4 ]
Harbeck, N. [6 ]
Huober, J. [5 ]
Karn, T. [1 ]
Komor, M. [2 ]
Lenhard, M. [7 ]
Loibl, S. [2 ]
Martin, B. [1 ]
Mueller, V. [8 ]
Niederacher, D. [9 ]
Rody, A. [1 ]
Roller, M. [2 ]
Schrauder, M. [10 ]
Thomssen, C. [11 ]
Kaufmann, M. [1 ]
机构
[1] Univ Frauenklin, Frankfurt, Germany
[2] German Breast Grp, Neu Isenburg, Germany
[3] Univ Klinikum Schleswig Holstein, Lubeck, Germany
[4] Georg Speyer Haus, Frankfurt, Germany
[5] Kantonsspital, Senolog Zentrum Ostschweiz, St Gallen, Switzerland
[6] Univ Frauenklin Rechts Isar, Munich, Germany
[7] Univ Munich, Frauenklin, Munich, Germany
[8] Univ Hamburg, Inst Tumorbiol, Univ Frauenklin Hamburg, Hamburg, Germany
[9] Univ Klinikum, Frauenklin, Dusseldorf, Germany
[10] Univ Klinikum, Frauenklin, Erlangen, Germany
[11] Univ Halle Wittenberg, Halle Wittenberg, Germany
关键词
translational research; therapy optimization; biomarkers; breast cancer;
D O I
10.1055/s-2008-1039167
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Translational Research in oncology links experimental and clinical science with the aim of transferring knowledge from research laboratories and hospitals and translating it into new therapy concepts. The definition of standards for the collection of biomaterials and the continued development of technologies are preconditions for Translational Research. Nevertheless new approaches are required to advance Translational Research. Following the invitation of the Banss Foundation, in September 2007 leading clinicians and scientists from German university hospitals and research facilities met together in Biedenkopf, near Marburg. The symposium aimed to develop new scientific concepts using aspects and features of innovation management. The topic was introduced by presenting general therapy concepts in breast cancer treatment (Prof. C. Thomssen) as well as current clinical breast cancer trials (Prof G. von Minckwitz). Translational Research was described from a clinical point of view (Prof. N. Harbeck) and from the point of view of the laboratory (Dr. D. Niederacher). The question "what we know and what we really should know" (Prof. B. Groner) was discussed during a presentation on the current state of knowledge in cancer research. This article summarizes the results of the discussion on central aspects of Translational Research in this workshop and offers new approaches.
引用
收藏
页码:1160 / 1165
页数:6
相关论文
共 9 条
[1]   Cancer stem cells in breast: Current opinion and future challenges [J].
Charafe-Jauffret, Emmanuelle ;
Monville, Florence ;
Ginestier, Christophe ;
Dontu, Gabriela ;
Birnbaum, Daniel ;
Wicha, Max S. .
PATHOBIOLOGY, 2008, 75 (02) :75-84
[2]   Genome-wide association study identifies novel breast cancer susceptibility loci [J].
Easton, Douglas F. ;
Pooley, Karen A. ;
Dunning, Alison M. ;
Pharoah, Paul D. P. ;
Thompson, Deborah ;
Ballinger, Dennis G. ;
Struewing, Jeffery P. ;
Morrison, Jonathan ;
Field, Helen ;
Luben, Robert ;
Wareham, Nicholas ;
Ahmed, Shahana ;
Healey, Catherine S. ;
Bowman, Richard ;
Meyer, Kerstin B. ;
Haiman, Christopher A. ;
Kolonel, Laurence K. ;
Henderson, Brian E. ;
Le Marchand, Loic ;
Brennan, Paul ;
Sangrajrang, Suleeporn ;
Gaborieau, Valerie ;
Odefrey, Fabrice ;
Shen, Chen-Yang ;
Wu, Pei-Ei ;
Wang, Hui-Chun ;
Eccles, Diana ;
Evans, D. Gareth ;
Peto, Julian ;
Fletcher, Olivia ;
Johnson, Nichola ;
Seal, Sheila ;
Stratton, Michael R. ;
Rahman, Nazneen ;
Chenevix-Trench, Georgia ;
Bojesen, Stig E. ;
Nordestgaard, Borge G. ;
Axelsson, Christen K. ;
Garcia-Closas, Montserrat ;
Brinton, Louise ;
Chanock, Stephen ;
Lissowska, Jolanta ;
Peplonska, Beata ;
Nevanlinna, Heli ;
Fagerholm, Rainer ;
Eerola, Hannaleena ;
Kang, Daehee ;
Yoo, Keun-Young ;
Noh, Dong-Young ;
Ahn, Sei-Hyun .
NATURE, 2007, 447 (7148) :1087-U7
[3]   Modelling the molecular circuitry of cancer [J].
Hahn, WC ;
Weinberg, RA .
NATURE REVIEWS CANCER, 2002, 2 (05) :331-341
[4]   Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 [J].
Jänicke, F ;
Prechtl, A ;
Thomssen, C ;
Harbeck, N ;
Meisner, C ;
Untch, M ;
Sweep, CGJF ;
Selbmann, HK ;
Graeff, H ;
Schmitt, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (12) :913-920
[5]   Therapeutic targeting of the tumor microenvironment [J].
Joyce, JA .
CANCER CELL, 2005, 7 (06) :513-520
[6]   MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study [J].
Kuhl, Christiane K. ;
Schrading, Simone ;
Bieling, Heribert B. ;
Wardelmann, Eva ;
Leutner, Claudia C. ;
Koenig, Roy ;
Kuhn, Walther ;
Schild, Hans H. .
LANCET, 2007, 370 (9586) :485-492
[7]   Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 8377 breast cancer patients [J].
Look, MP ;
van Putten, WLJ ;
Duffy, MJ ;
Harbeck, N ;
Christensen, IJ ;
Thomssen, C ;
Kates, R ;
Spyratos, F ;
Fernö, M ;
Eppenberger-Castori, S ;
Sweep, CGJF ;
Ulm, K ;
Peyrat, JP ;
Martin, PM ;
Magdelenat, H ;
Brünner, N ;
Duggan, C ;
Lisboa, BW ;
Bendahl, PO ;
Quillien, V ;
Daver, A ;
Ricolleau, G ;
Meijer-van Gelder, E ;
Manders, P ;
Fiets, WE ;
Blankenstein, MA ;
Broët, P ;
Romain, S ;
Daxenbichler, G ;
Windbichler, G ;
Cufer, T ;
Borstnar, S ;
Kueng, W ;
Beex, LVAM ;
Klijn, JGM ;
O'Higgins, N ;
Eppenberger, U ;
Jänicke, F ;
Schmitt, M ;
Foekens, JA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (02) :116-128
[8]   A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer [J].
Paik, S ;
Shak, S ;
Tang, G ;
Kim, C ;
Baker, J ;
Cronin, M ;
Baehner, FL ;
Walker, MG ;
Watson, D ;
Park, T ;
Hiller, W ;
Fisher, ER ;
Wickerham, DL ;
Bryant, J ;
Wolmark, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2817-2826
[9]   Gene expression profiling of breast cancer: A new tumor marker [J].
van't Veer, LJ ;
Paik, S ;
Hayes, DF .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) :1631-1635